Jules Alexandre Desmeules

Ontology type: schema:Person     

Person Info


Jules Alexandre



Publications in SciGraph latest 50 shown

  • 2021-08-31 Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review in CLINICAL PHARMACOKINETICS
  • 2021-07-01 Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult Patients in DRUGS
  • 2020-08-26 Safety of the Geneva Cocktail, a Cytochrome P450 and P-Glycoprotein Phenotyping Cocktail, in Healthy Volunteers from Three Different Geographic Origins in DRUG SAFETY
  • 2019-10-29 Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more? in INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
  • 2019-10-10 Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling in PEDIATRIC RESEARCH
  • 2019-05-27 Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches in CLINICAL PHARMACOKINETICS
  • 2019-02-19 A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder in BMC PSYCHIATRY
  • 2018-04-17 Complex Drug–Drug–Gene–Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives in CLINICAL PHARMACOKINETICS
  • 2018-02-16 Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites in CLINICAL PHARMACOKINETICS
  • 2017-11-07 Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study) in BMC PHARMACOLOGY AND TOXICOLOGY
  • 2014-10-24 Improving the primary care physicians’ decision making for fibromyalgia in clinical practice: development and validation of the Fibromyalgia Detection (FibroDetect®) screening tool in HEALTH AND QUALITY OF LIFE OUTCOMES
  • 2014-08-04 Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity in AIDS RESEARCH AND THERAPY
  • 2014-04-10 Geneva Cocktail for Cytochrome P450 and P-Glycoprotein Activity Assessment Using Dried Blood Spots in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2013-11-19 Individualisation thérapeutique et analgésiques : vers une médecine personnalisée in DOULEUR ET ANALGÉSIE
  • 2013-11-15 Intérêt des outils d’investigation des enzymes métaboliques en pratique clinique in DOULEUR ET ANALGÉSIE
  • 2013-11-15 Pharmacogénétique des anti-inflammatoires non stéroïdiens in DOULEUR ET ANALGÉSIE
  • 2013-11-11 Douleur chronique : rôle de la pharmacogénétique dans la résistance aux antidépresseurs in DOULEUR ET ANALGÉSIE
  • 2013-11-11 Utilisation des analgésiques dans l’insuffisance hépatique in DOULEUR ET ANALGÉSIE
  • 2013-10-25 Influence des polymorphismes génétiques sur la variabilité de la réponse aux opioïdes in DOULEUR ET ANALGÉSIE
  • 2013-04-16 Applications of CYP450 Testing in the Clinical Setting in MOLECULAR DIAGNOSIS & THERAPY
  • 2012-10-04 La multidisciplinarité, une réponse à la complexité. Exemples d’application en Suisse in DOULEUR ET ANALGÉSIE
  • 2012-08-19 Identification and weighting of the most critical “real-life” drug–drug interactions with acenocoumarol in a tertiary care hospital in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2012-01-11 Oral Flurbiprofen Metabolic Ratio Assessment Using a Single‐Point Dried Blood Spot in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2012-01-06 Analgesics in Patients with Hepatic Impairment in DRUGS
  • 2009-09 Low-Energy Femoral Fractures Associated with the Long-Term Use of Bisphosphonates in DRUG SAFETY
  • 2008-07-01 The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction in THE PHARMACOGENOMICS JOURNAL
  • 2007-12 Rôle de la sensibilisation centrale dans la fibromyalgie in DOULEUR ET ANALGÉSIE
  • 2006-09 De la légitime méfiance à l’alliance thérapeutique in DOULEUR ET ANALGÉSIE
  • 2006-09 Coxibes: où en sommes-nous? in DOULEUR ET ANALGÉSIE
  • 2006-09 Existe-t-il un rationnel justifiant la combinaison du paracétamol aux anti-inflammatoires non stéroïdiens? in DOULEUR ET ANALGÉSIE
  • 2006-04-27 CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2005-10 Genetic polymorphism and drug interactions: their importance in the treatment of pain in JOURNAL CANADIEN D'ANESTHÉSIE
  • 2005-02-05 Lack of dextromethorphan interaction with P‐glycoprotein in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2005-02 Assessment of naltrexone antagonism of buprenorphine in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2005-02 Pharmacokinetics and analgesic effects of intravenous buprenorphine in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2004-06 Analgésie, l’importance du polymorphisme génétique du cytochrome P450 2D6 dans l’individualisation thérapeutique in DOULEUR ET ANALGÉSIE
  • 2004-06 Influence du cycle menstruel sur le seuil de la douleur expérimentale in DOULEUR ET ANALGÉSIE
  • 2004-06 Douleurs rebelles et ébranlements traumatiques in DOULEUR ET ANALGÉSIE
  • 2004-06 Quel rôle pour la glycoprotéine-P dans l’activité analgésique des opioïdes? in DOULEUR ET ANALGÉSIE
  • 2004-06 Douleur et culture: quelques questions de méthode liées à la mesure de la dimension culturelle in DOULEUR ET ANALGÉSIE
  • 2003-07-25 Rofecoxib interaction with oral anticoagulant acenocoumarol in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2003-02-16 Drug interaction detection using epocrates in a walk‐in clinic in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2003-02-16 Medication and end‐of‐life: A review of terminally ill cancer patients' drug treatments in the hospital in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2003-02 Methadone and QT interval in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2001-09 Genre et douleur: rôle du cycle menstruel in DOULEUR ET ANALGÉSIE
  • 2001-09 Utilisation des antidépresseurs chez les patients souffrant de douleurs chroniques: quelle congruence entre prescription et notice d’emballage? in DOULEUR ET ANALGÉSIE
  • 2001-09 Risques rénaux des anti-inflammatoires non stéroïdiens COX 2 sélectifs in DOULEUR ET ANALGÉSIE
  • 1999-02 The mixed analgesic effects of tramadol enantiomers in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.8591.5", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "http://www.grid.ac/institutes/grid.412370.3", 
            "type": "Organization"
            "id": "http://www.grid.ac/institutes/grid.7429.8", 
            "type": "Organization"
            "id": "http://www.grid.ac/institutes/grid.6612.3", 
            "type": "Organization"
            "id": "http://www.grid.ac/institutes/grid.412004.3", 
            "type": "Organization"
            "id": "http://www.grid.ac/institutes/grid.483664.b", 
            "type": "Organization"
            "id": "http://www.grid.ac/institutes/grid.21107.35", 
            "type": "Organization"
            "id": "http://www.grid.ac/institutes/grid.9851.5", 
            "type": "Organization"
            "id": "http://www.grid.ac/institutes/grid.42505.36", 
            "type": "Organization"
            "id": "http://www.grid.ac/institutes/grid.150338.c", 
            "type": "Organization"
        "familyName": "Desmeules", 
        "givenName": "Jules Alexandre", 
        "id": "sg:person.01266555141.71", 
        "identifier": [
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0003-2702-1795"
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2022-01-01T19:56", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/person/person_684.jsonl", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01266555141.71'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01266555141.71'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01266555141.71'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01266555141.71'


    This table displays all metadata directly associated to this object as RDF triples.

    39 TRIPLES      11 PREDICATES      22 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01266555141.71 schema:affiliation N46fbd0b946d54ef6975914feb6a27ebf
    2 grid-institutes:grid.150338.c
    3 grid-institutes:grid.21107.35
    4 grid-institutes:grid.412004.3
    5 grid-institutes:grid.412370.3
    6 grid-institutes:grid.42505.36
    7 grid-institutes:grid.483664.b
    8 grid-institutes:grid.6612.3
    9 grid-institutes:grid.7429.8
    10 grid-institutes:grid.9851.5
    11 schema:familyName Desmeules
    12 schema:givenName Jules Alexandre
    13 schema:identifier N9c3dbc88a28a4454a3ace4985b88fab0
    14 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01266555141.71
    15 https://orcid.org/0000-0003-2702-1795
    16 schema:sdDatePublished 2022-01-01T19:56
    17 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    18 schema:sdPublisher Nd6d80c14bbb349239cc6f9ee349ba17a
    19 sgo:license sg:explorer/license/
    20 sgo:sdDataset persons
    21 rdf:type schema:Person
    22 N46fbd0b946d54ef6975914feb6a27ebf schema:affiliation grid-institutes:grid.8591.5
    23 sgo:isCurrent true
    24 rdf:type schema:OrganizationRole
    25 N9c3dbc88a28a4454a3ace4985b88fab0 schema:name orcid_id
    26 schema:value 0000-0003-2702-1795
    27 rdf:type schema:PropertyValue
    28 Nd6d80c14bbb349239cc6f9ee349ba17a schema:name Springer Nature - SN SciGraph project
    29 rdf:type schema:Organization
    30 grid-institutes:grid.150338.c schema:Organization
    31 grid-institutes:grid.21107.35 schema:Organization
    32 grid-institutes:grid.412004.3 schema:Organization
    33 grid-institutes:grid.412370.3 schema:Organization
    34 grid-institutes:grid.42505.36 schema:Organization
    35 grid-institutes:grid.483664.b schema:Organization
    36 grid-institutes:grid.6612.3 schema:Organization
    37 grid-institutes:grid.7429.8 schema:Organization
    38 grid-institutes:grid.8591.5 schema:Organization
    39 grid-institutes:grid.9851.5 schema:Organization

    Preview window. Press ESC to close (or click here)